'Literally life-changing': Island family celebrating after B.C. announces funding for cystic fibrosis drug for kids
It appears impassioned calls on the B.C. government to fund a cystic fibrosis drug for young children has been heard by policy makers.
On Wednesday, the province announced it would be expanding its eligibility criteria for the drug Trikafta to include young children aged six to 11 starting on Sept. 13.
B.C. is the last province to approve the drug's use in kids of this age group, a delay that was painfully apparent to the family of 10-year-old Maysa Milligan, who has cystic fibrosis and lives in Courtenay, B.C.
Maysa's mother, Sarah Milligan, has been calling on the province to approve the drug for young children, since every other province in Canada began funding it earlier this year.
Trikafta was approved for adults in 2021 by Health Canada, and was later approved for young children this spring.
On Wednesday evening, Milligan said she was thrilled by the announcement.
"This is literally life-changing for our entire family. Like, this is going to impact Maysa’s health so much, it has the potential to impact Maysa’s health so much," she said.
The family lives in Courtenay, but frequently travels to Victoria General Hospital for treatments.
"It may mean that her health improves to the point we can consider doing less of the therapies that we have to do," said Milligan.
With eligibility criteria for Trikafta expanding next week, the family expects Maysa will be able to start taking the drug near the end of September.
"I can't wait for the 13th to come," said Maysa. "I know that will be a game-changer for my life."
"I can't wait to finally have that [Trikafta] in my hands, but I do wish it could have come a little bit sooner," said the 10-year-old.
Ten-year-old Maysa Milligan is pictured.
'DRAGGING ITS FEET'
On Aug. 30, Milligan told CTV News that the province was "dragging its feet" on approving a treatment that could change the life of her child.
"Every day that goes by she loses a little," she said at the time.
"She gains scar tissue in her lungs that we can't ever undo. So the longer it takes to get access to these medications the sicker she gets," said Milligan.
One day after CTV News shared the family's story, Cystic Fibrosis Canada said it had received word from the provincial government that it would be approving the use of Trikafta in young chilren in mid-September.
Milligan was thrilled by the announcement, but was still puzzled why the province was going to wait weeks to get the drug into families' hands.
"It doesn't make sense to allow them to get worse before they get better. We know they're going to approve it, so the delay is unacceptable," she said on Aug. 31.
'WORKED TIRELESSLY FOR THIS DAY'
The B.C. government says about 150 people currently use Trikafta PharmaCare coverage. Once the eligibility criteria expands next week, that total could double with approximately 185 more people eligible to receive funding for the drug.
The Milligan family had previously told CTV News that without funding, it would cost about $300,000 a year to purchase the medication.
Trikafta is funded through the B.C. Expensive Drugs for Rare Diseases process, which provides funding for medications for rare conditions on a case-by-case basis.
Cystic fibrosis is a progressive disease that affects about 500 people in B.C., according to the province. The disease primarily affects the lungs but can harm other organs as well.
"Today’s news will change the trajectory of the disease and the future for many children and adults in British Columbia who live with cystic fibrosis," said Kelly Grover, president and CEO of Cystic Fibrosis Canada in a statement Wednesday.
"We celebrate this news alongside our cystic fibrosis community in British Columbia, who has worked tirelessly for this day that has finally come," she said.
With files from CTV News Vancouver Island's Robert Buffam
CTVNews.ca Top Stories
'Still so much love between us,' Sophie Gregoire Trudeau says of Prime Minister Justin Trudeau
Sophie Gregoire Trudeau says there is 'still so much love' between her and Prime Minister Justin Trudeau, as they navigate their post-separation relationship co-parenting their three children.
What to know about avian influenza in dairy cows and the risk to humans
Why is H5N1, or bird flu, a concern, how does it spread, and is there a vaccine? Here are the answers to some frequently asked questions about avian influenza.
'I was scared': Ontario man's car repossessed after missing two repair loan payments
An Ontario man who took out a loan to pay for auto repairs said his car was repossessed after he missed two payments.
opinion The special relationship between King Charles and the Princess of Wales
Royal commentator Afua Hagan writes that when King Charles recently admitted Catherine to the Order of the Companions of Honour, it not only made history, but it reinforced the strong bond between the King and his beloved daughter-in-law.
Pro-plastic lobbyist presence at UN talks is 'troubling,' say advocates
Environmentalist groups are sounding the alarm about a steep increase in the number of pro-plastic lobbyists at the UN pollution talks taking place this week.
'Too young to have breast cancer': Rates among young Canadian women rising
Breast cancer rates are rising in Canada among women in their 20s, 30s and 40s, according to research by the University of Ottawa (uOttawa).
Charlie Woods, son of Tiger, shoots 81 in U.S. Open qualifier
Charlie Woods failed to advance in a U.S. Open local qualifying event Thursday, shooting a 9-over 81 at Legacy Golf & Tennis Club.
$70M Lotto Max winners kept prize a secret from family for 2 months
During a special winner celebration near their hometown, Doug and Enid shared the story of how they discovered they were holding a Lotto Max ticket worth $70 million and how they kept this huge secret for so long.
Trump's lawyers grill ex-tabloid publisher as 1st week of hush money trial testimony nears a close
After prosecutors' lead witness painted a tawdry portrait of “catch-and-kill” tabloid schemes, defence lawyers in Donald Trump's criminal trial on Friday sought to dig into an account of the former publisher of the National Enquirer and his efforts to protect Trump from negative stories during the 2016 election.